Cellbricks
Regenerative Medicine & 3D Bioprinting
0 open roles Regenerative Medicine & 3D Bioprinting Berlin, Germany 28 employees $11M raised Est. 2016
Brooks Hill Partners
ACT Venture Partners
B.Value
The Engine
better ventures (Germany)
Stern Stewart Ventures
About Cellbricks
- Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity.
- It is a pre-clinical-stage tissue therapeutic company developing a new class of tissue implants based on a proprietary light-based 3D-bioprinting platform that is designed to replicate human tissue at scale.
- They aim to develop advanced soft and liver tissue implants for over a hundred million patients.
Cellbricks is listed on Rocketlist with 0 active roles. The company is categorized as Regenerative Medicine & 3D Bioprinting in BioTech. Cellbricks is at Seed stage, with a B2B and B2C business model, headquartered in Berlin, Germany. Cellbricks was founded in 2016 and has 28 employees. Cellbricks has raised $11M. Active roles are refreshed daily from public hiring sources.